Oral presentation shares head-to-head results for investigational combination pozelimab plus cemdisiran vs. ravulizumab in paroxysmal nocturnal hemoglobinuria Initial results for odronextamab in first ...
Real-world data showed mean BMI decrease of 12.8% in adult patients with acquired hypothalamic obesity (N=8) at three months ...
Becomes first company to showcase four routes of synthesis for approved siRNA therapeutic asset——Joint poster with Bachem demonstrates ...
According to The Wall Street Journal, “Every Company Needs to Put on a Show Like Steve Jobs.” The article quotes Airbnb co-founder Brian Chesky and other leaders who admired Jobs’ product launches and ...
Zacks Small Cap Research on MSN10h
INAB: Upcoming Presentations at SNO & ASHINAB READ THE FULL INAB RESEARCH REPORT IN8bio, Inc (NASDAQ:INAB) reported third quarter 2024 financial results and achievements on November 12th. Activity since the second quarter update was ...
Global Healthy Living Foundation has 12 posters and Polymyalygia Rheumataca, Psoriasis and RA Research at American College of ...
In the technical session, Bijay Singh, former ICAR national professor at PAU, Ludhiana, emphasised the need to rethink ...
Abstract #5038: Volixibat for Cholestatic Pruritus in Primary Biliary Cholangitis: An Adaptive, Randomized, Placebo-controlled Phase 2b Trial (VANTAGE): Interim Results **Late-breaker poster ...
Clinical data from the RESET-Myositis™ and RESET-SLE™ trials, along with initial clinical data from the RESET-SSc™ trial, to be presented this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback